Autopsy report · NCT07253688

Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“After reviewing the recruitment to date as well as considering the anticipated ongoing recruitment challenges and feasibility, the decision was made to close the study.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 10 months before it stopped.
1 participant enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: Todd C. Lee MD MPH FIDSA
Sponsor type: University, hospital or other
Conditions: Staphylococcus Aureus Endocarditis; Prosthetic Valve Endocarditis
Interventions: Rifampin; No rifampin
Participants: 1
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.